Trials / Unknown
UnknownNCT03010410
Platelet Immune Responses in Aging and Influenza and Sepsis (INVACS)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Intermountain Health Care, Inc. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Aging is associated with immunosenescence and impaired host defense mechanisms, contributing to influenza-related morbidity and mortality. Preliminary data demonstrate that the platelet transcriptome is markedly different between healthy subjects and influenza patients. Interferon-induced transmembrane proteins (IFITM) family members are among the transcripts significantly increased in platelets during influenza and expression of IFITM-3 is impaired in elderly subjects, a pattern associated with increased mortality. This study will build on these data and investigate if aging influences the expression of platelet IFITM family members in patients with influenza and sepsis. This study will prospectively determine if aging alters the induction of (IFITMs) in platelets from hospitalized influenza and sepsis patients. The study will also determine if diminished expression of IFITM family members correlates with an increased risk of adverse outcomes in older influenza and sepsis patients.
Detailed description
This will be a prospective observational cohort study comparing older (age≥65) and younger (age\<65) influenza and sepsis patients.
Conditions
Timeline
- Start date
- 2014-12-21
- Primary completion
- 2019-10-01
- Completion
- 2019-12-01
- First posted
- 2017-01-05
- Last updated
- 2019-08-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03010410. Inclusion in this directory is not an endorsement.